Novartis Applauds Medicare Rx Pilot; Overall Bill “Somewhat Negative”

Novartis hopes to see some immediate benefit from the Medicare prescription drug law from a Centers for Medicare & Medicaid Services pilot program to study expanded coverage of oral chemotherapy drugs